Time from Symptom Onset to Hospitalisation of Coronavirus Disease 2019 (COVID-19) Cases: Implications for the Proportion of Transmissions from Infectors with Few Symptoms
Abstract
:1. Introduction
2. Methods
2.1. Time from Symptom Onset to Hospitalisation
2.2. Time-Varying Reproduction Number
2.3. Proportion of Transmissions from Individuals with Few Symptoms
3. Results
3.1. Time from Symptom Onset to Hospitalisation
3.2. Reproduction Number and Proportion of Transmissions from Individuals with Few Symptoms
4. Discussion
Supplementary Materials
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Thompson, R.N. Novel coronavirus outbreak in Wuhan, China, 2020: Intense surveillance is vital for preventing sustained transmission in new locations. J. Clin. Med. 2020, 9, 498. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Stoecklin, S.; Rolland, P.; Silue, Y.; Mailles, A.; Campese, C.; Simondon, A.; Yamani, E. First cases of coronavirus disease 2019 (COVID-19) in France: Surveillance, investigations and control measures, January 2020. Eurosurveillance 2020, 25, 2000094. [Google Scholar]
- Gostic, K.M.; Gomez, A.C.R.; Mummah, R.O.; Kucharski, A.J.; Lloyd-Smith, J.O. Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19. Elife 2020, 9, 55570. [Google Scholar] [CrossRef] [PubMed]
- Hellewell, J.; Abbott, S.; Gimma, A.; Bosse, N.I.; Jarvis, C.I.; Russell, T.W.; Munday, J.D.; Kucharski, J.; Edmunds, J. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob. Health 2020, 8, E488–E496. [Google Scholar] [CrossRef] [Green Version]
- Spina, S.; Marrazzo, F.; Migliari, M.; Stucchi, R.; Sforza, A.; Fumagalli, R. The response of Milan’s Emergency Medical System to the COVID-19 outbreak in Italy. Lancet 2020, 395, E49–E50. [Google Scholar] [CrossRef] [Green Version]
- Clifford, S.J.; Pearson, C.A.B.; Klepac, P.; Van Zandvoort, K.; Quilty, B.J.; CMMID COVID-19 Working Group; Eggo, R.M.; Flasche, S. Effectiveness of interventions targeting air travellers for delaying local outbreaks of SARS-CoV-2. medRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
- Fauci, A.S.; Lane, H.C.; Redfield, R.R. Covid-19—Navigating the uncharted. N. Engl. J. Med. 2020, 382, 1268–1269. [Google Scholar] [CrossRef]
- Anzai, A.; Kobayashi, T.; Linton, N.M.; Kinoshita, R.; Hayashi, K.; Suzuki, A.; Yang, Y.; Jung, S.-M.; Miyama, T.; Akhmetzhanov, A.R.; et al. Assessing the Impact of Reduced Travel on Exportation Dynamics of Novel Coronavirus Infection (COVID-19). J. Clin. Med. 2020, 9, 601. [Google Scholar] [CrossRef] [Green Version]
- Chen, S.; Yang, J.; Yang, W.; Wang, C.; Bärnighausen, T. COVID-19 control in China during mass population movements at New Year. Lancet 2020, 395, 764–766. [Google Scholar] [CrossRef] [Green Version]
- Thompson, R.N. Pandemic potential of 2019-nCoV. Lancet Infect. Dis. 2020, 3099, 30068. [Google Scholar] [CrossRef] [Green Version]
- Wilder-Smith, A.; Freedman, D.O. Isolation, quarantine, social distancing and community containment: Pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak. J Travel Med. 2020, 2, taaa020. [Google Scholar] [CrossRef] [PubMed]
- Fraser, C.; Riley, S.; Anderson, R.M.; Ferguson, N.M. Factors that make an infectious disease outbreak controllable. Proc. Natl. Acad. Sci. USA 2004, 101, 6146–6151. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lipsitch, M.; Swerdlow, D.L.; Finelli, L. Defining the epidemiology of Covid-19—Studies needed. N. Engl. J. Med. 2020, 382, 1194–1196. [Google Scholar] [CrossRef] [PubMed]
- Ferretti, L.; Wymant, C.; Kendall, M.; Zhao, L.; Nurtay, A.; Abeler-Dörner, L.; Parker, M.; Bonsall, D.; Fraser, C. Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing. Science 2020, eabb6936. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Guan, W.-J.; Ni, Z.-Y.; Hu, Y.; Liang, W.-H.; Ou, C.-Q.; He, J.-X.; Liu, L.; Shan, H.; Lei, C.-L.; Hui, D.S.; et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020. [Google Scholar] [CrossRef]
- Chen, N.; Zhou, M.; Dong, X.; Qu, J.; Gong, F.; Han, Y.; Qiu, Y.; Wang, J.; Liu, Y.; Wei, Y.; et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020, 395, 507–513. [Google Scholar] [CrossRef] [Green Version]
- Yeo, C.; Kaushal, S.; Yeo, D. Enteric involvement of coronaviruses: Is faecal–oral transmission of SARS-CoV-2 possible? Lancet Gastroenterol. Hepatol. 2020, 5, 335–337. [Google Scholar] [CrossRef] [Green Version]
- Bai, Y.; Yao, L.; Wei, T.; Tian, F.; Jin, D.-Y.; Chen, L.; Wang, M. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA 2020, 323, 1406. [Google Scholar] [CrossRef] [Green Version]
- Rothe, C.; Schunk, M.; Sothmann, P.; Bretzel, G.; Froeschl, G.; Wallrauch, C.; Zimmer, T.; Thiel, V.; Janke, C.; Guggemos, W.; et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N. Engl. J. Med. 2020, 382, 970–971. [Google Scholar] [CrossRef] [Green Version]
- Pan, X.; Chen, D.; Xia, Y.; Wu, X.; Li, T.; Ou, X.; Zhou, L.; Liu, J. Asymptomatic cases in a family cluster with SARS-CoV-2 infection. Lancet Infect. Dis. 2020, 20, 410–411. [Google Scholar] [CrossRef]
- Li, R.; Pei, S.; Chen, B.; Song, Y.; Zhang, T.; Yang, W.; Shaman, J. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). Science 2020, eabb3221. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nishiura, H.; Kobayashi, T.; Suzuki, A.; Jung, S.-M.; Hayashi, K.; Kinoshita, R.; Yang, Y.; Yuan, B.; Akhmetzhanov, A.R.; Linton, N.M.; et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int. J. Infect. Dis. 2020. [Google Scholar] [CrossRef] [PubMed]
- Chen, Z.; Hu, J.; Zhang, Z.; Jiang, S.S.; Wang, T.; Daszak, P.; Zhang, Z. Caution: The clinical characteristics of COVID-19 patients at admission are changing. medRxiv 2020. [Google Scholar] [CrossRef]
- Yang, P.; Ding, Y.; Xu, Z.; Pu, R.; Li, P.; Yan, J.; Liu, J.; Meng, F.; Huang, L.; Shi, L.; et al. Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, China. medRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
- Nishiura, H.; Kobayashi, T.; Yang, Y.; Hayashi, K.; Miyama, T.; Kinoshita, R.; Linton, N.M.; Jung, S.-M.; Yuan, B.; Suzuki, A.; et al. The Rate of Underascertainment of Novel Coronavirus (2019-nCoV) Infection: Estimation Using Japanese Passengers Data on Evacuation Flights. J. Clin. Med. 2020, 9, 419. [Google Scholar] [CrossRef] [Green Version]
- Wu, Z.; McGoogan, J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020, 323, 1239–1242. [Google Scholar] [CrossRef]
- Tong, Z.-D.; Tang, A.; Li, K.-F.; Li, P.; Wang, H.-L.; Yi, J.-P. Potential presymptomatic transmission of SARS-CoV-2, Zhejiang Province, China, 2020. Emerg. Infect Dis. 2020, 26, 1052–1054. [Google Scholar] [CrossRef] [Green Version]
- Kraemer, M.; Pigott, D.; Xu, B.; Hill, S.; Gutierrez, B.; Pybus, O. Epidemiological Data from the nCoV-2019 Outbreak: Early Descriptions from Publicly Available Data. 2020. Available online: http://virological.org/t/epidemiological-data-from-the-ncov-2019-outbreak-early-descriptions-from-publicly-available-data/ (accessed on 9 February 2020).
- Linton, N.M.; Kobayashi, T.; Yang, Y.; Hayashi, K.; Akhmetzhanov, A.R.; Jung, S.-M.; Yuan, B.; Kinoshita, R.; Nishiura, H. Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data. J. Clin. Med. 2020, 9, 538. [Google Scholar] [CrossRef] [Green Version]
- Cori, A.; A Donnelly, C.; Dorigatti, I.; Ferguson, N.M.; Fraser, C.; Garske, T.; Jombart, T.; Nedjati-Gilani, G.; Nouvellet, P.; Riley, S.; et al. Key data for outbreak evaluation: Building on the Ebola experience. Philos. Trans. R. Soc. B Boil. Sci. 2017, 372, 20160371. [Google Scholar] [CrossRef] [Green Version]
- Mizumoto, K.; Kagaya, K.; Zarebski, A.; Chowell, G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Eurosurveillance 2020, 25, 2000180. [Google Scholar] [CrossRef] [Green Version]
- Thompson, R.; Stockwin, J.; Van Gaalen, R.; Polonsky, J.; Kamvar, Z.; DeMarsh, P.; Dahlqwist, E.; Li, S.; Miguel, E.; Jombart, T.; et al. Improved inference of time-varying reproduction numbers during infectious disease outbreaks. Epidemics 2019, 29, 100356. [Google Scholar] [CrossRef] [PubMed]
- Cori, A.; Ferguson, N.M.; Fraser, C.; Cauchemez, S. A new framework and software to estimate time-varying reproduction numbers during epidemics. Am. J. Epidemiol. 2013, 178, 1505–1512. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nishiura, H.; Chowell, G. The Effective Reproduction Number as a Prelude to Statistical Estimation of Time-Dependent Epidemic Trends. In Mathematical and Statistical Estimation Approaches in Epidemiology; Springer: Berlin/Heidelberg, Germany, 2009; pp. 103–121. [Google Scholar]
- Fraser, C. Estimating individual and household reproduction numbers in an emerging epidemic. PLoS ONE 2007, 2, 758. [Google Scholar] [CrossRef]
- Forsberg White, L.; Pagano, M. A likelihood-based method for real-time estimation of the serial interval and reproduction number of an epidemic. Stat. Med. 2008, 27, 2999–3016. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Heymann, D.L.; Shindo, N. WHO Scientific and Technical Advisory Group for Infectious Hazards. COVID-19: What is next for public health? Lancet 2020, 395, 542–545. [Google Scholar] [CrossRef] [Green Version]
- Kucharski, A.J.; Russell, T.W.; Diamond, C.; Liu, Y.; Edmunds, J.; Funk, S.; Eggo, R.M.; Sun, F.; Jit, M.; Munday, J.D.; et al. Early dynamics of transmission and control of COVID-19: A mathematical modelling study. Lancet Infect. Dis. 2020. [Google Scholar] [CrossRef] [Green Version]
- Flaxman, S.; Mishra, S.; Gandy, A.; Unwin, J.T.; Coupland, H.; Mellan, T.; Eaton, J.; Perez Guzman, P.; Cilloni, L.; Schmit, N.; et al. Estimating the Number of Infections and the Impact of Non-Pharmaceutical Interventions on COVID-19 in 11 European Countries. Available online: https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-Europe-estimates-and-NPI-impact-30-03-2020.pdf (accessed on 4 April 2020).
- Reich, N.G.; Lessler, J.; Cummings, D.A.T.; Brookmeyer, R. Estimating incubation period distributions with coarse data. Stat. Med. 2009, 28, 2769–2784. [Google Scholar] [CrossRef]
- He, X.; Lau, E.H.Y.; Wu, P.; Deng, X.; Wang, J.; Hao, X.; Lau, Y.C.; Wong, J.Y.; Guan, Y.; Tan, X.; et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat. Med. 2020, 1–4. [Google Scholar] [CrossRef] [Green Version]
- Ganyani, T.; Kremer, C.; Chen, D.; Torneri, A.; Faes, C.; Wallinga, J.; Hens, N. Estimating the generation interval for COVID-19 based on symptom onset data. medRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Thompson, R.N.; Lovell-Read, F.A.; Obolski, U. Time from Symptom Onset to Hospitalisation of Coronavirus Disease 2019 (COVID-19) Cases: Implications for the Proportion of Transmissions from Infectors with Few Symptoms. J. Clin. Med. 2020, 9, 1297. https://doi.org/10.3390/jcm9051297
Thompson RN, Lovell-Read FA, Obolski U. Time from Symptom Onset to Hospitalisation of Coronavirus Disease 2019 (COVID-19) Cases: Implications for the Proportion of Transmissions from Infectors with Few Symptoms. Journal of Clinical Medicine. 2020; 9(5):1297. https://doi.org/10.3390/jcm9051297
Chicago/Turabian StyleThompson, Robin N., Francesca A. Lovell-Read, and Uri Obolski. 2020. "Time from Symptom Onset to Hospitalisation of Coronavirus Disease 2019 (COVID-19) Cases: Implications for the Proportion of Transmissions from Infectors with Few Symptoms" Journal of Clinical Medicine 9, no. 5: 1297. https://doi.org/10.3390/jcm9051297
APA StyleThompson, R. N., Lovell-Read, F. A., & Obolski, U. (2020). Time from Symptom Onset to Hospitalisation of Coronavirus Disease 2019 (COVID-19) Cases: Implications for the Proportion of Transmissions from Infectors with Few Symptoms. Journal of Clinical Medicine, 9(5), 1297. https://doi.org/10.3390/jcm9051297